1. Sweeney L.B., Stewart C, Gaitonde DY. Thyroiditis: an integrated approach//Am Fam Physician. - 2014. - Vol. 90, N 6. - P. 389 - 96.

2. Strakosch CR. Thyroiditis//Aust N Z J Med. - 1986. - Vol. 16, N 1. - P. 91 - 100.

3. Paes JE, Burman KD, Cohen J, Franklyn J, McHenry CR, Shoham S, Kloos RT. Acute bacterial suppurative thyroiditis: a clinical review and expert opinion.//Thyroid. - 2010. - Vol. 20, N 3. - P. 247 - 55.

4. Slatosky J, Shipton B, Wahba H. Thyroiditis: Differential Diagnosis and Management//Am Fam Physician. - 2000. - Vol. 61, N 4. - P. 1047 - 1052.

5. Shrestha RT, Hennessey J. Acute and Subacute, and Riedel's Thyroiditis//www.Endotext.org Last Update: December 8, 2015. (https://www.ncbi.nlm.nih.gov/books/NBK285553/)

6. Bindra A, Braunstein GD "Thyroiditis".//Am Fam Physician. 2006: 73 (10): 1769 - 76.

7. Goichot B, Caron P, Landron F, S. Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters. Clin Endocrinol (Oxf) 2015 published online May 9. DOI: 10.1111/cen.12816.

8. Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ 2003 Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 88: 2100 - 2105

9. Benbassat CA, Olchovsky D, Tsvetov G, Shimon I 2007 Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest 30: 631 - 635.

10. Keely EJ, Postpartum thyroiditis: an autoimmune thyroid disorder which predicts future thyroid health//Obstet Med. 2011 Mar; 4(1): 7 - 11. doi: 10.1258/om.2010.100041

11. Mincer DL; Jialal I Hashimoto Thyroiditis//Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Last Update: May 5, 2019.

12. Girgis CM, Champion BL, Wall JR Current Concepts in Graves" Disease//Ther Adv Endocrinol Metab. 2011 Jun; 2(3): 135 - 144 doi: 10.1177/2042018811408488.

13. Эндокринология. Национальное руководство/под ред. акад. И.И. Дедова, акад. Г.А. Мельниченко. - М.: ГЭОТАР-Медиа, 2016. - с. 638 - 640.

14. Bonnyns M, Vanhaelst L, Bastenie PA. Asymptomatic atrophic thyroiditis.//Horm Res. 1982; 16(5): 338 - 344.

15. Veit F, Graf D, Momberger S, Helmich-Kapp B, Ruschenburg I, Peters A, Kussmann J, Saeger W, Schmidt KW, Toetsch M, Nestler K⁰, Mann K Papillary Thyroid Cancer and Coexisting Autoimmune Thyroiditis.//Horm Metab Res. 2017 Nov; 49(11): 869 - 872. doi: 10.1055/s-0043-120922. Epub 2017 Nov 14.

16. D, Matesa N, N, Z. Coexistence of papillary carcinoma and Hashimoto"s thyroiditis. Acta Clin Croat. 2009 Mar; 48(1): 9 - 12.

17. Gopalakrishnan S, Marwaha RK. Juvenile autoimmune thyroiditis.//J Pediatr Endocrinol Metab. 2007 Sep; 20(9): 961 - 70.

18. Лебедева Е.А., Яблонская Ю.А., Булгакова С.В. Амиодарон-индуцированный тиреотоксикоз. Современный взгляд на проблему//Клиническая и экспериментальная тиреоидология. - 2017. - Т. 13. - N 2. - С. 31 - 38.

19. Свириденко Н.Ю., Платонова Н.М., Молашенко Н.В., Голицин С.П., Бакалов С.А., Сердюк С.Е. Эндокринные аспекты применения амиодарона в клинической практике. (Алгоритм наблюдения и лечения функциональных расстройств щитовидной железы)//Российский кардиологический журнал 2012, 2 (94): 63 - 71.

20. Rizzo LFL, Mana DL, Serra HA Drug-induced hypothyroidism. Medicina (B Aires). 2017; 77(5): 394 - 404.

21. Enio Martino, Luigi Bartalena, Fausto Bogazzi, Lewis E. Braverman, The Effects of Amiodarone on the Thyroid, Endocrine Reviews, Volume 22, Issue 2, 1 April 2001, Pages 240 - 254, https://doi.org/10.1210/edrv.22.2.0427

22. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009 Dec; 23(6): 723 - 33 doi: 10.1016/j.beem.2009.06.002.

23. Furlow B Immunotherapy Patients Should Be Monitored for Destructive Thyroiditis ATA Thyroid Cancer 2016, Thyroid Cancer

24. Falhammar H, Juhlin CC, Barner C, Catrina S-B, Karefylakis C, Calissendorff J Riedel's thyroiditis: clinical presentation, treatment and outcomes Endocrine. 2018; 60(1): 185 - 192.

25. Мельниченко Г.А., Ларина И.И. Синдром тиреотоксикоза. Дифференциальная диагностика и лечение. Терапевтический архив. 2018; 10: 4 - 13.

26. Rizzo LF, Mana DL, Bruno OD. Non-autoimmune thyroiditis. Medicina (B Aires). 2014; 74(6): 481 - 92.

27. Melmed, Shlomo, Kenneth S. Polonsky, and P. R. Larsen "Acute Infectious Thyroiditis." Willams Textbook of Endocrinology. By Henry M. Kronenberg. 11th ed. Philadelphia: Elsevier, 2008. 945 - 47.

28. Berger SA, Zonszein J, Villamena P, Mittman N 1983 Infectious diseases of the thyroid gland. Rev Infect Dis 5: 108 - 122.

29. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE 2006 Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55: 1 - 17; quiz CE11 - CE14.

30. Falhammar H, Wallin G, Calissendorff J. Acute suppurative thyroiditis with thyroid abscess in adults: clinical presentation, treatment and outcomes. BMC Endocr Disord. 2019 Dec 3; 19(1): 130. doi: 10.1186/s12902-019-0458-0.

31. Yolmo D, Madana J, Kalaiarasi R, et al. Retrospective case review of pyriform sinus fistulae of third branchial arch origin commonly presenting as acute suppurative thyroiditis in children. J Laryngol Otol. 2012; 126: 737 - 742.

32. Brook I 2003 Microbiology and management of acute suppurative thyroiditis in children. Int J Pediatr Otorhinolaryngol 67: 447 - 451

33. Al-Dajani N, Wootton SH 2007 Cervical lymphadenitis, suppurative parotitis, thyroiditis, and infected cysts. Infect Dis Clin North Am 21: 523 - 541, viii.

34. Kale SU, Kumar A, David VC 2004 Thyroid abscess - an acute emergency. Eur Arch Otorhinolaryngol 261: 456 - 458.

35. Chrobok V, Celakovsky P, Nunez-Fernandez D, Simakova E 2000 Acute purulent thyroiditis with retropharyngeal and retrotracheal abscesses. J Laryngol Otol 114: 151 - 153.

36. Mollar-Puchades MA, Camara-Gomez R, Perez-Guillen V, Benavides-Gabernet M, Gomez-Vela J, Pinon-Selles F 2006 Thyroid hematoma and infectious thyroiditis after a neck injury. Thyroid 16: 421 - 422.

37. McLaughlin SA, Smith SL, Meek SE 2006 Acute suppurative thyroiditis caused by Pasteurella multocida and associated with thyrotoxicosis. Thyroid 16: 307 - 310.

38. Agarwal A, Mishra SK, Sharma AK 1998 Acute suppurative thyroiditis with demonstrable distant primary focus: a report of two cases. Thyroid 8: 399 - 401.

39. Kim KH, Sung MW, Koh TY, Oh SH, Kim IS 2000 Pyriform sinus fistula: management with chemocauterization of the internal opening. Ann Otol Rhinol Laryngol 109: 452 - 456.

40. Miyauchi A, Inoue H, Tomoda C, Amino N 2009 Evaluation of chemocauterization treatment for obliteration of pyriform sinus fistula as a route of infection causing acute suppurative thyroiditis. Thyroid 19: 789 - 793.

41. Ammar Asban, Sophie Dream, Brenessa Lindeman. 2019. Is Hyperthyroidism Diagnosed and Treated Appropriately in the United States? Advances in Surgery 53, 117 - 129.

42. Stasiak M, Tymoniuk B, Stasiak B, A The Risk of Recurrence of Subacute Thyroiditis Is HLA-Dependent//Int J Mol Sci. 2019 Mar 3; 20(5). pii: E1089. doi: 10.3390/ijms20051089.

43. E. Nishihara, H. Ohye, N. Amino et al., "Clinical characteristics of 852 patients with subacute thyroiditis before treatment", Internal Medicine, vol. 47, no. 8, pp. 725 - 729, 2008.

44. A.A. Alfadda, R.M. Sallam, G.E. Elawad, H. Aldhukair, and M. M. Alyahya. Subacute thyroiditis: clinical presentation and long term outcome//International Journal of Endocrinology. - Vol. 2014. Article ID 794943, 7 pages, 2014.

45. Pearce, Elizabeth M.D., Alan P. Farwell M.D. and Lewis E. Braverman M.D. "Thyroiditis." The New England Journal of Medicine. 2003 June 26; 348: 2646 - 2655.

46. Frates MC, Marqusee E, Benson CB, Alexander EK 2013 Subacute granulomatous (de Quervain) thyroiditis: grayscale and color Doppler sonographic characteristics. J Ultrasound Med 32: 505 - 511.

47. Woolf PD 1980 Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocr Rev 1: 411 - 420.

48. Carle A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB, Laurberg P 2013 Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. Eur J Endocrinol 169: 537 - 545.

49. Erdem N, Erdogan M, Ozbek M, Karadeniz M, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C, Tuzun M, Kabalak T 2007 Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey. J Endocrinol Invest 30: 546 - 550.

50. Cappelli C, Pirola I, Gandossi E, Formenti AM, Agosti B, Castellano M 2014 Ultrasound findings of subacute thyroiditis: a single institution retrospective review. Acta Radiol 55: 429 - 433.

51. Izumi Y, Hidaka Y, Tada H, Takano T, Kashiwai T, Tatsumi KI, Ichihara K, Amino N 2002 Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis. Clin Endocrinol (Oxf) 57: 51 - 58.

52. Rishi Raj, Srujana Yada, Aasems Jacob, Dileep Unnikrishnan, and Wael Ghali Fever of Unknown Origin as a Sole Presentation of Subacute Thyroiditis in an Elderly Patient: A Case Report with Literature Review//Case Reports in Endocrinology. - Volume 2018. P. 1 - 8. Article ID 5041724.

53. Kubota S, Nishihara E, Kudo T, Ito M, Amino N, Miyauchi A 2013 Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan. Thyroid 23: 269 - 272.

54. Ruzieh M, Moroi M, Aboujamous N et al. Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo. Am J Cardiol. 2019. doi: 10.1016/j.amjcard.2019.09.008.

55. Ahmed S, Van Gelder I, Wiesfeld A, Van Veldhuisen D, Links T. Determinants and outcome of amiodarone-associated thyroid dysfunction. Clin Endocrinol (Oxf). 2011; 75(3): 388 - 394. doi: 10.1111/j.1365-2265.2011.04087.

56. Bogazzi, F., Martino, E., Dell'Unto, E. et al. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest 26, 635 - 640 (2003). https://doi.org/10.1007/BF03347021

57. Eaton SE, Euinton HA, Newman CM, et al. Clinical experience of amiodarone induced thryotoxicosis over a 3-year period: Role of colour-flow Doppler sonography. Clin Endocrinol. 2002; 56: 33 - 8

58. Theodoraki A, Vanderpump MPJ. Thyrotoxicosis associated with the use of amiodarone: the utility of ultrasound in patient management. Clin Endocrinol (Oxf) 2016; 84: 172 - 176.

59. Pattison D, Westcott J, Lichtenstein M et al. Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis. Nucl Med Commun. 2015; 36(4): 356 - 362.

60. Censi S, Bodanza V, Manso J et al. Amiodarone-Induced Thyrotoxicosi: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR). Clin Nucl Med. 2018; 43(9): 655 - 662.

61. Piga M., Cocco M.C, Serra A., Boi F., Loy M., Mariotti S. The usefulness of 99m-Tc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis//Eur J Endocrinol. 2008. 159(4), 423 - 429.

62. Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, Aujesky D, Bauer DC, Baumgartner C, Blum MR, Browne JP, Byrne S, Collet TH, Dekkers OM, denElzen WPJ, DuPuy RS, Ellis G, Feller M, Floriani C, Hendry K, Hurley C, Jukema JW, Kean S, Kelly M, Krebs D, Langhorne P, McCarthy G, McCarthy V, McConnachie A, McDade M, Messow M, O'Flynn A, O'Riordan D, Poortvliet RKE, Quinn TJ, Russell A, Sinnott C, Smit JWA, Van Dorland HA, Walsh KA, Walsh EK, Watt T, Wilson R, Gussekloo J; TRUST Study Group: Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 2017; 376: 2534 - 2544.

63. Prajapati S. Hernandez-Prera, J.C. Putting All the Pieces Together: Clinical, Macroscopic and Microscopic Characteristics of Subacute Thyroiditis//Head Neck Pathol. 2019 Jun; 13(2): 231 - 234. doi: 10.1007/s12105-018-0890-x. Epub 2018 Feb 9.

64. Bogazzi F, Bartalena L, Martino E: Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2010; 95: 2529 - 2535.

65. Thiel A, Schott M. Treatment of Amiodarone-Induced Thyrotoxicosis Type 2: A Randomized Clinical Trial. Yearbook of Endocrinology. 2012; 2012: 151 - 153. doi: 10.1016/j.yend.2012.05.036.

66. Krishnan A, Khan E. Amiodarone induced thyrotoxicosis? type2. Endocrine Abstracts. 2017. doi: 10.1530/endoabs.48.cb7

67. Tomisti L, Materazzi G, Bartalena L, Rossi G, Marchello A, Moretti M, De Napoli L, Mariotti R, Miccoli P, Martino E, Bogazzi F: Total thyroidectomy in patients with amiodarone induced thyrotoxicosis and severe left ventricular systolic dysfunction. J Clin Endocrinol Metab 2012; 97: 3515 - 3521.

68. Kaderli RM, Fahrner R, Christ ER, Stettler C, Fuhrer J, Martinelli M, Vogt A, Seiler CA: Total thyroidectomy for amiodarone-induced thyrotoxicosis in the hyperthyroid state. Exp Clin Endocrinol Diabetes 2016; 124: 45 - 48.

69. Houghton SG, Farley DR, Brennan MD, van Heerden JA, Thompson GB, Grant CS: Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. World J Surg 2004; 28: 1083 - 1087.

70. Gough J, Gough IR: Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 2006; 30: 1957 - 1961.

71. Cappellani D, Papini P, Pingitore A et al. Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis. The Journal of Clinical Endocrinology & Metabolism. 2019. doi: 10.1210/clinem/dgz041.

72. Bogazzi, F., Tomisti, L., Ceccarelli, C., & Martino, E. (2010). Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note. Clinical Endocrinology, 72(1), 133 - 134. doi: 10.1111/j.1365-2265.2009.03600.x

73. Steinke JW., Borish L. Cytokines and chemokines. The Journal of Allergy and Clinical Immunology. - 2006. - 117 N 2. - P. 441 - 445.

74. J., E., Quadros P., Vidal S., I., JA., L., V. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection//Journal of Medical Virology. - 2008. - 80 N 9. - P. 1588 - 1594.

75. Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism//The Journal of Infectious Diseases. - 2003. - 188 N 8. - P. 1192 - 1204.

76. Balasubramanian A, Ganju RK, Groopman JE. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes.//The Journal of Infectious Diseases. - 2006. - 194 N 5. - P. 670 - 681.

77. Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes//The Journal of Biological Chemistry. - 2003. - 278 N 37. - P. 35755 - 35766.

78. Моргунова Т.Б., Решетник Н.А., Фадеев В.В. Цитокининдуцированные тиреопатии//Клиническая и экспериментальная тиреоидология. - 2010. - Т. 7 - N 1. - С. 19 - 28.

79. Bini EJ., Mehandru S. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study//Archives of Internal Medicine. - 2004. - 164 N 21. - P. 2371 - 2376.

80. Chang YK., Tseng YT., Chen KH., Chen KT. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan//BMC Endocr Disord. - 2019. - 19 N 1. - P. 36.

81. Koh LK., Greenspan FS., Yeo PP. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature//Thyroid. - 1997. - 7 N 6. - P. 891 - 896.

82. Tomer Y, Menconi F. Interferon induced thyroiditis//Best Practice and Research in Clinical Endocrinology and Metabolism. - 2009. - 23 N 6. - P. 703 - 712.

83. Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification//Hepatology. - 2006. - 43 N 4. P. 661 - 672.

84. J, Wawrzynowicz-Syczewska M, Urbanowicz W, J, Syrenicz A. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C//Endokrynol Pol. - 2011. - 62(6) - P. 517 - 22.

85. Barbesino G Drugs affecting thyroid function//Thyroid 2010. - 20: 763 - 770.

86. Lazarus JH. Effect of lithium on the thyroid gland. In Weetman AP & Grossman A (eds.). Pharmacotherapeutics of the thyroid gland. Berlin, Germany: Springer-Verlag, 1997, pp. 207 - 218.

87. Kibirige D, Luzinda K, Ssekitoleko R. Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res. 2013; 6(1): 3. Published 2013 Feb 7. doi: 10.1186/1756-6614-6-3.

88. Kraszewska A, Ziemnicka K, K, J, Rybakowski JK. Thyroid structure and function in long-term lithium-treated and bipolar patients. Hum Psychopharmacol Clin Exp. 2019; 2011(3): 026988111988285. doi: https://doi.org/10.1002/hup.2708

89. Lazarus JH, Ludgate M, McGregor A et al. Lithium therapy induces autoimmune thyroid disease. In Walfish PG, Wall JR & Volpe R (eds.). Autoimmunity and the thyroid. London: Academic Press, 1985, pp. 319 - 320.

90. Kraszewska A, Ziemnicka K, J, Ferensztajn-Rochowiak E, Rybakowski JK. No Connection between Long-Term Lithium Treatment and Antithyroid Antibodies. Pharmacopsychiatry. 2019; 52(05): 232 - 236.

91. Mizukami Y, Michigishi T, Nonomura A, Nakamura S, Noguchi M, Takazakura E. Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis. J Clin Pathol. 1995; 48(6): 582 - 584.

92. Kirov G, Tredget J, John R, Owen MJ, Lazarus JH. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J Affect Disord. 2005; 87(2 - 3): 313 - 317.

93. Lazarus JH. The Effects of Lithium Therapy on Thyroid and Thyrotropin-Releasing Hormone. Thyroid. 1998; 8(10): 909 - 913.

94. Brownlie BEW, Turner JG. Lithium associated thyrotoxicosis. Clin Endocrinol (Oxf). 2011; 75(3): 402 - 403.

95. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26(10): 1343 - 1421.

96. Martino, E., Macchia, E., Aghini-Lombardi, F., Antonelli, A., Lenziardi, M., Concetti, R., Fenzi, G.F., Baschieri, L. And Pinchera, A. (1986), Is Humoral Thyroid Autoimmunity Relevant In Amiodarone Iodine-Induced Thyrotoxicosts (Aiit)?. Clinical Endocrinology, 24: 627 - 633. doi: 10.1111/j.1365-2265.1986.tb01658.x

97. Tomisti L, Urbani C, Rossi G, et al. The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis. J Endocrinol Invest. 2016; 39(5): 585 - 591. doi: 10.1007/s40618-015-0426-0

98. Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J. 2018; 7(2): 55 - 66. doi: 10.1159/000486957

99. Lieber I, Ott M, L, et al. Lithium-associated hypothyroidism and potential for reversibility after lithium discontinuation: Findings from the LiSIE retrospective cohort study. J Psychopharmacol. 2019; 2011(3): 026988111988285.

100. McClellan J, Kowatch R, Findling RL. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(1): 107 - 125.

101. Panwar V, Lassi K. Stable Bipolar Patient Switched to Mania following Clinical Doses of Prednisone. Case Rep Psychiatry. 2011; 2011(3): 1 - 2.

102. Heufelder AE, Hay ID. Evidence for autoimmune mechanisms in the evolution of invasive fibrous thyroiditis (Riedel"s struma)//Clin Investig. - 1994. - 72(10). - P. 788 - 93.

103. Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, Mori I, Nagayama K, Nakamura H, Kakudo K. Immunohistochemistry of IgG4 can help subclassify Hashimoto"s autoimmune thyroiditis//Pathol. Int. - 2009. - 59(9). - P. 636 - 41.

104. Gosi SKY, Garla VV. Riedel Thyroiditis//StatPearls Publishing. - 2019.

105. Papi G, LiVolsi VA. Current concepts on Riedel thyroiditis//Am J Clin Pathol. - 2004. - P. 121: S50 - S63.

106. Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V. Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976 - 2008//Thyroid. - 2011. - 21(7) - P. 765 - 72.

107. James V Hennessey Clinical review: Riedel"s thyroiditis: a clinical review//The Journal of Clinical Endocrinology & Metabolism, Volume 96, Issue 10, 1 October 2011, Pages 3031 - 3041.

108. Papi G, Corrado S, Cesinaro AM, Novelli L, Smerieri A, Carapezzi C. Riedel"s thyroiditis: clinical, pathological and imaging features//Int. J. Clin. Pract. - 2002. - 56(1). - P. 65 - 7.

109. Ozgen A, Cila A. Riedel"s thyroiditis in multifocal fibrosclerosis: CT and MR imaging findings//AJNR Am J Neuroradiol. - 2000. - 21(2). - P. 320 - 1.

110. Few J, Thompson NW, Angelos P, Simeone D, Giordano T, Reeve T. Riedel"s thyroiditis: treatment with tamoxifen//Surgery. - 1996. - 120(6). - P. 993 - 8; 998 - 9.

111. Rick Schneider, MD; Gregory W. Randolph, et al. International Neural Monitoring Study Group Guideline 2018 Part I: Staging Bilateral Thyroid Surgery With Monitoring Loss of Signal. Laryngoscope 2018 Oct; 128 Suppl 3: S1 - S17. doi: 10.1002/lary.27359. Epub 2018 Oct 5.

112. Che-Wei Wu, MD, PhD; Gianlorenzo Dionigi, MD, FACS; Marcin Barczynski, MD, PhD, FEBS-ES; Feng-Yu Chiang, MD; Henning Dralle, MD, et al. International Neuromonitoring Study Group Guidelines 2018: Part II: Optimal Recurrent Laryngeal Nerve Management for Invasive Thyroid Cancer - Incorporation of Surgical, Laryngeal, and Neural Electrophysiologic Data Laryngoscope 2018 Oct; 128 Suppl 3: S18 - S27. doi: 10.1002/lary.27360. Epub 2018 Oct 6.

113. Dimos, G., G. Pappas, and N. Akritidis, Subacute thyroiditis in the course of novel H1N1 influenza infection. Endocrine, 2010. 37(3): p. 440 - 1.

114. Volta, C., et al., Atypical subacute thyroiditis caused by Epstein-Barr virus infection in a three-year-old girl. Thyroid, 2005. 15(10): p. 1189 - 91.

115. Bouillet, B., et al., A case of subacute thyroiditis associated with primary HIV infection. Am J Med, 2009. 122(4): p. e5 - 6.

116. Satoh, M., Virus-like particles in the follicular epithelium of the thyroid from a patient with subacute thyroiditis (deQuervain"s). Acta Pathol Jpn, 1975. 25: p. 499 - 501.

117. Engkakul, P., P. Mahachoklertwattana, and P. Poomthavorn, de Quervain thyroiditis in a young boy following hand-foot-mouth disease. Eur J Pediatr, 2011. 170(4): p. 527 - 9.

118. Stasiak M, Tymoniuk B, Michalak R, Stasiak B, Kowalski ML, A. Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01 - The Significance of the New Molecular Background. J Clin Med. 2020; 9(2): 534. Published 2020 Feb 16.

119. Kojima M, Nakamura S, Oyama T, Sugihara S, Sakata N, Masawa N: Cellular composition of subacute thyroiditis: an immunohistochemical study of six cases. Pathol Res Pract 2002, 198: 833 - 837.

120. Wasniewska, M., et al., Acute suppurative thyroiditis in childhood: spontaneous closure of sinus pyriform fistula may occur even very early. J Pediatr Endocrinol Metab, 2007. 20(1): p. 75 - 7.

121. Ogawa, E., et al., Subacute thyroiditis in children: patient report and review of the literature. J Pediatr Endocrinol Metab, 2003. 16(6): p. 897 - 900.

122. Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med Clin North Am. 2014; 32: 277 - 92.

123. Boelaert K, Torlinska B, Holder RL, Franklyn JA. Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab. 2010; 95: 2715 - 26.

124. Ruchala, M., et al., The role of sonoelastography in acute, subacute and chronic thyroiditis - a novel application of the method. Eur J Endocrinol, 2011.

125. Stasiak, M., Michalak, R. & Lewinski, A. Thyroid primary and metastatic malignant tumours of poor prognosis may mimic subacute thyroiditis - time to change the diagnostic criteria: case reports and a review of the literature. BMC Endocr Disord 19, 86 (2019).

126. Koirala KP, Sharma V. Treatment of Acute Painful Thyroiditis with Low Dose Prednisolone: A Study on Patients from Western Nepal. J Clin Diagn Res. 2015; 9(9): MC01 - MC3.

127. Lee IS, Lee JU, Lee KJ, Jang YS, Lee JM, Kim HS. Painful immunoglobulin G4-related thyroiditis treated by total thyroidectomy. Korean J Intern Med. 2016; 31(2): 399 - 402.

128. Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K. Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010; 95: 1309 - 1317.

129. Qari FA, Maimani AA. Subacute thyroiditis in Western Saudi Arabia//Saudi Med J. 2005 Apr; 26(4): 630 - 3.

130. Tagami T, Yambe Y, Tanaka T, Tanaka T, Ogo A, Yoshizumi H, Kaise K, Higashi K, Tanabe M, Shimazu S, Usui T, Shimatsu A, Naruse M, BBGD Study Group 2012 Shortterm effects of beta-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease. Intern Med 51: 2285 - 2290.

131. Samuels MH. Subacute, silent, and postpartum thyroiditis. Med. Clin. North Am. 2012 Mar; 96(2): 223 - 33.

132. Sato J, Uchida T, Komiya K, Goto H, Takeno K, Suzuki, et al. Comparison of the therapeutic effects of prednisolone and non-steroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine. (2017) 55: 209 - 14.

133. Arao T, Okada Y, Torimoto K, Kurozumi A, Narisawa M, Yamamoto S, Tanaka Y. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis//J UOEH. 2015 Jun 1; 37(2): 103 - 10.

134. Stasiak M, Michalak R, Stasiak B, A. Time-Lag Between Symptom Onset and Diagnosis of Subacute Thyroiditis - How to Avoid the Delay of Diagnosis and Unnecessary Overuse of Antibiotics. Horm Metab Res. 2020; 52(1): 32 - 38. doi: 10.1055/a-1033-7524.

135. Mazza E, Quaglino F, Suriani A, et al. Thyroidectomy for Painful Thyroiditis Resistant to Steroid Treatment: Three New Cases with Review of the Literature. Case Rep Endocrinol. 2015; 2015: 138327.

136. Nishihara, E., et al., Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis. J Endocrinol Invest, 2009. 32(1): p. 33 - 6.

137. Saklamaz A. Is there a drug effect on the development of permanent hypothyroidism in subacute thyroiditis?//Acta Endocrinol (Buchar). 2017 Jan - Mar; 13(1): 119 - 123.

138. Gotzsche LS, Boye N, Laurberg P, Andreasen F 1989 Rat heart thyroxine 5'-deiodinase is sensitively depressed by amiodarone. J Cardiovasc Pharmacol 14: 836 - 841.

139. Trohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019; 29(5): 285 - 295. doi: https://doi.org/10.1016/j.tcm.2018.09.005

140. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone iodine-induced hypothyroid-ism: risk factors and follow-up in 28 cases. Clin Endocrinol (Oxf). 1987; 26(2): 227 - 237. doi: 10.1111/j.1365-2265.1987.tb00781.x

141. Basaria S, Cooper DS 2005 Amiodarone and the thyroid. Am J Med 118: 706 - 714.

142. Wong R, Cheung W, Stockigt JR, Topliss DJ 2003 Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response. Intern Med J 33: 420 - 426.

143. Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP, Wiersinga WM 2012 Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab 97: 499 - 506.

144. Stan MN, Sathananthan M, Warnes CA, Brennan MD, Thapa P, Bahn RS 2014 Amiodarone-induced thyrotoxicosis in adults with congenital heart disease - clinical presentation and response to therapy. Endocr Pract 20: 33 - 40.

145. Bogazzi F, Bartalena L, Tomisti L, Rossi G, Brogioni S, Martino E 2011 Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study.

146. Maqdasy S., Batisse-Lignier M., Auclair C, et al. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction. Am J Cardiol. 2016; 117(7): 1112 - 1116.

147. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab. 1996; 81(8): 2930 - 2933. doi: 10.1210/jcem.81.8.8768854

148. Czarnywojtek A, Czepczynski R, Ruchala M, et al. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT). Neuro Endocrinol Lett. 2009; 30(2): 209 - 214.

149. Hermida JS, Tcheng E, Jarry G, et al. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias. Europace. 2004; 6(2): 169 - 174. doi: 10.1016/j.eupc.2003.11.002

150. Gursoy A, Tutuncu NB, Gencoglu A, Anil C, Demirer AN, Demirag NG. Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis. J Natl Med Assoc. 2008; 100(6): 716 - 719. doi: 10.1016/s0027-9684(15)31348-1

151. Xu S, Jiang Y, Jia A, Zhang J, Gao B, Xu J, Jing X, Jiao Y, Wei J, Xu W, Chen R, Gao L, Shang L. Comparison of the therapeutic effects of 15 mg and 30 mg initial dosage of prednisolone daily in patients with subacute thyroiditis: protocol for a multicenter, randomized, open, parallel control study. Trials. 2020 May 24; 21(1): 418. doi: 10.1186/s13063-020-04337-8. PMID: 32448401; PMCID: PMC7245742.

152. Яхья А.Д.М. Клинические особенности течения подострого тиреоидита и современные методы его лечения//Международный эндокринологический журнал. - 2011. - N 1 (33).

153. Huber G, Staub J-J, Meier C, et al. Prospective Study of the Spontaneous Course of Subclinical Hypothyroidism: Prognostic Value of Thyrotropin, Thyroid Reserve, and Thyroid Antibodies. J Clin Endocrinol Metab. 2002; 87(7): 3221 - 3226. doi: https://doi.org/10.1210/jcem.87.7.8678